RSVAX
Price
$25.61
Change
-$0.07 (-0.27%)
Updated
Aug 28 closing price
Net Assets
258.48M
VMVAX
Price
$89.47
Change
-$0.27 (-0.30%)
Updated
Aug 28 closing price
Net Assets
31.04B
Interact to see
Advertisement

RSVAX vs VMVAX

Header iconRSVAX vs VMVAX Comparison
Open Charts RSVAX vs VMVAXBanner chart's image
Victory RS Value A
Price$25.61
Change-$0.07 (-0.27%)
VolumeN/A
Net Assets258.48M
Vanguard Mid-Cap Value Index Admiral
Price$89.47
Change-$0.27 (-0.30%)
VolumeN/A
Net Assets31.04B
RSVAX vs VMVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSVAX vs. VMVAX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSVAX is a Buy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 31B vs. RSVAX (258M). VMVAX pays higher dividends than RSVAX: VMVAX (2.22) vs RSVAX (0.37). RSVAX was incepted earlier than VMVAX: RSVAX (32 years) vs VMVAX (14 years). RSVAX (1.33) is less costly to investors than VMVAX (0.07). RSVAX is a more actively managed with annual turnover of: 39.00 vs. VMVAX (19.00). RSVAX has a lower initial minimum investment than VMVAX: RSVAX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 6.80 vs. RSVAX (-5.66). VMVAX return over 5 years is better than : 67.15 vs. RSVAX (25.59).
RSVAXVMVAXRSVAX / VMVAX
Total Expense Ratio1.300.071,857%
Annual Report Gross Expense Ratio1.330.071,900%
Fund Existence32 years14 years-
Gain YTD3.0507.18042%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets258M31B1%
Annual Yield % from dividends0.372.2217%
Returns for 1 year-5.666.80-83%
Returns for 3 years3.8726.1715%
Returns for 5 years25.5967.1538%
Returns for 10 years-16.58102.24-16%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEGAX15.75N/A
N/A
abrdn Emerging Markets A
ALARX53.67N/A
N/A
Alger Capital Appreciation Instl I
IJSTX13.97N/A
N/A
VY® JPMorgan Small Cap Core Equity S2
PSCNX18.09N/A
N/A
Penn Capital Special Sits Sm Cp Eq Inst
FRGSX121.80N/A
N/A
Franklin Growth C